SDS Biotech K.K. reported consolidated earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported net sales of ¥7,242 million against ¥6,638 million a year ago. Operating income was ¥402 million against ¥337 million a year ago. Ordinary income was ¥231 million against ¥230 million a year ago. Net income was ¥181 million or ¥23.13 per diluted share against ¥117 million or ¥15.00 per diluted share a year ago. Net income before taxes was ¥228,312,000 against ¥232,027,000 a year ago.

The company provided consolidated earnings guidance for the fiscal year ending March 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.

The company provided dividend guidance for the year ended March 31, 2016. For the year the company expects to pay dividend of ¥15.00 as compared to ¥10.00 last year.